FDA Device Intelligence
HomeLUMINEX CORPORATION › Gram-Negative Blood Culture (BC-GN) Extraction Tray

Gram-Negative Blood Culture (BC-GN) Extraction Tray

LUMINEX CORPORATION · Model 20-009-021 · UDI-DI 00840487101643

PEN Prescription
1
510(k) clearances
59
Adverse events (12 deaths)
20
Recalls
4
Facilities

Description

The Verigene® Gram-Negative Blood Culture Nucleic Acid Test (BC-GN) performed using the sample-to-result Verigene® System, is a qualitative multiplexed in vitro diagnostic test for the simultaneous detection and identification of selected gram-negative bacteria and resistance markers.

Recalls

DateFirmReason
2025-04-16Luminex CorporationIt was determined that the consumable issue may result in No Call - INT CTL 1 and/or False Negative results on a small portion of the lot of test cartridges.
2024-06-19BioFire Diagnostics, LLCIf blood culture identification panel is used in conjunction with specific lots of culture media bottles, then false positive Serratia marcescens results may occur, due to an incre
2024-01-26BioFire Diagnostics, LLCDue to a trend in false positive Candida tropicalis results on blood culture panel when using certain BD BACTEC vial mediums
2023-10-17BioFire Diagnostics, LLCRoutine quality control testing of affected blood culture identification panel with affected control panel may need to be amended, due to control panel/instrument characteristic ch
2023-02-01BioFire Diagnostics, LLCDue to temperature excursions with products (products being stored outside of the required temperature specifications) that may cause a reduction in performance. The temperature e
2021-10-11BioFire Diagnostics, LLCDue to an increased risk of false positive Acinetobacter calcoaceticus- baumannii complex results. The cause may be as a due to non-viable contamination in the blood culture vials
2021-07-20BioFire Diagnostics, LLCDue to product complaints received for false negative results (dropouts) with blood culture identification panel potential caused by a pouch manufacturing error.
2021-05-10BioFire Diagnostics, LLCElevated rates of false negative results may occur when using blood culture panels due to issues in the manufacturing process. Pouches contained OPP from FilmArray Blood Culture Id
2021-01-26BioFire Diagnostics, LLCThe firm has identified an increased risk of false positive Pseudomonas aeruginosa when BCID/BCID2 Panels are used with specific BD BACTEC" blood culture vials.
2021-01-26BioFire Diagnostics, LLCThe firm has identified an increased risk of false positive Pseudomonas aeruginosa when BCID/BCID2 Panels are used with specific BD BACTEC" blood culture vials.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.